Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy
Marc A Miller*, J Anthony Gomes and Valentin Fuster
Correspondence *Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1030, New York, NY 10029, USA
Email marc.miller@mssm.edu
Identifying high-risk individuals with hypertrophic cardiomyopathy is paramount as the first clinical expression is often the most devastating—sudden cardiac death. Miller and colleagues review the established or 'major' risk factors used to identify high-risk patients, and discuss the possible and future risk factors for hypertrophic cardiomyopathy-related sudden cardiac death.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Routine delivery of myoblasts during coronary artery bypass surgery: why not?Nature Clinical Practice Cardiovascular Medicine Article (01 Mar 2006)
See all 5 matches for Research